Polymyalgia Rheumatica could be safely, effectively treated with tofacitinib, avoiding the need for steroids, per new proof-of-concept Randomized Controlled Trial

Polymyalgia Rheumatica could be safely, effectively treated with tofacitinib, avoiding the need for steroids, per new proof-of-concept Randomized Controlled Trial

#####

In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004249

Article Title: Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial

Author Countries: China

Funding: This work was supported by Natural Science Foundation of China (82171768 to WQC), National Key Research and Development Program of China (2022YFC3602000 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.